Itamar Medical Ltd (NASDAQ:ITMR)

30.25
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
16.36
Today|||52-Week Range
30.46
+52.32%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$497.0M

Company Description

Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a proven predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur on January 15, 1997 and is headquartered in Caesarea, Israel.

Contact Information

Itamar Medical Ltd.
9 Halamish Street
Caesarea Haifa 3079883
P:(724) 617-7000
Investor Relations:

Employees

Shareholders

Mutual fund holders8.02%
Other institutional34.86%
Individual stakeholders--

Top Executives

Gilad GlickPresident, CEO & VP-Sales & Marketing
Shy BassonChief Financial Officer
Efrat LitmanVice President-Advanced Research & Development
Jennifer CookGlobal Medical Director
Eilon LivneVP-Sales & Channels Development